Log In
Sign Up
Acute myeloid (myelogenous, nonlymphocytic) leukemia in adults; hormone-refractory prostate cancer. (In combination with other chemotherapeutic agents)
IV 100-120mg/m2, given on Day 1 of cycle or divided into 2 doses and given on Day 1 and Day 8. It is repeated every 21–28 days for 6 cycles [in combination with other chemotherapy agents]. Consult specialist literature for further information.
Mode of action
Side Effects
Pregnancy risk
Special information
Brands containing this Ingredient
Name Form. Strength Pack Price Insert Manufacturer Distributor
Drug Index 2.0 is here
Our new update features a more powerful search feature and easier login. Having any issues? Contact us today. Contact Us